References
- Shi T, McAllister DA, O’Brien KL, et al. Global, regional, and national disease burden estimates of acute lower respiratory infections due to respiratory syncytial virus in young children in 2015: a systematic review and modelling study. Lancet Lond Engl. 2017;390(10098):946–8. .
- Banerji A, Panzov V, Young M, et al. Hospital admissions for lower respiratory tract infections among infants in the Canadian Arctic: a cohort study. CMAJ Open. 2016;4(4):E615–E622. .
- Bruden DJT, Singleton R, Hawk CS, et al. Eighteen years of respiratory syncytial virus surveillance: changes in Seasonality and hospitalization rates in Southwestern Alaska Native Children. Pediatr Infect Dis J. 2015;34(9):945–950. .
- Singleton RJ, Bruden D, Brooks L, et al. Closer to home: local care improves compliance with RSV prophylaxis in high-risks infants. Int J Circumpolar Health. 2006;65(1). [Online] https://doi.org/https://doi.org/10.3402/ijch.v65i1.17886
- Zhou H, Thompson WW, Viboud CG, et al. Hospitalizations associated with influenza and respiratory syncytial virus in the USA, 1993-2008. Clin Infect Dis. 2012;54(10):1427–1436. .
- The IMpact-RSV Study Group. Palivizumab, a humanized respiratory syncytial virus monoclonal antibody, reduces hospitalization from respiratory syncytial virus infection in high-risk infants. Pediatrics. 1998;102(3):531–537. .
- Andabaka T, Nickerson JW, Rojas-Reyes MX, et al. Monoclonal antibody for reducing the risk of respiratory syncytial virus infection in children. Cochrane Database Syst Rev. 2013;30(4):CD006602.
- Feltes TF, Cabalka AK, Meer HC, et al. Palivizumab prophylaxis reduces hospitalization due to respiratory syncytial virus in young children with hemodynamically significant congenital heart disease. J Pediatr. 2003;143(4):532–540. .
- Kua KP, Lee SWH. Systematic review of the safety and efficacy of palivizumab among infants and young children with cystic fibrosis. Pharmacotherapy. 2017;37(6):755–769.
- Simões EAF, Bont L, Manzoni P, et al. Past, present and future approaches to the prevention and treatment of respiratory syncytial virus infection in Children. Infect Dis Ther. 2018;7(1):87–120. .
- Banerji A, Panzov V, Young M, et al. The real-life effectiveness of palivizumab for reducing hospital admissions for respiratory syncytial virus in infants residing in Nunavut. Can Respir J. 2014;21(3):185–189. .
- Singleton RJ, Dooley L, Bruden D, et al. Impact of palivizumab prophylaxis on respiratory syncytial virus hospitalizations in high risk Alaska Native infants. Pediatr Infect Dis J. 2003;22(6):540–545.
- Héma-Québec. 2016. Circulaire HQ-16-021. Informations sur la disponibilité du Synagis pour la saison 2016-2017: [Online] https://www.hema-quebec.qc.ca/userfiles/file/media/francais/hopitaux/16-021.pdf
- Institut national d’excellence en santé et en services sociaux (INESSS). 2016. Reevaluation of eligibility criteria for palivizumab (Synagis) for the prevention of severe syncytial respiratory virus infections in children [Online] https://www.inesss.qc.ca/fileadmin/doc/INESSS/Rapports/Medicaments/INESSS_Report_Synagis_EN.pdf?sword_list%5B0%5D=domicile&no_cache=1INSPQ 2004. Nunavik Health Survey 2004: [En ligne] https://www.inspq.qc.ca/node/2566
- Tri-Council Policy Statement 2. Ethical conduct and research involving humans. Ottawa: Secretariat on Responsible Conduct of Research, Government of Canada, 2019; 2018. [Online] https://ethics.gc.ca/eng/documents/tcps2-2018-en-interactive-final.pdf
- Fraser S, Rouillard R, Nadeau L, et al. Collaborating to improve child and youth mental health in Nunavik. Études/Inuit/Studies. 2016;40(1):23–41.
- Cerigo H, Macdonald ME, Franco EL, et al. Inuit women’s attitudes and experiences towards cervical cancer and prevention strategies in Nunavik, Quebec. Int J Circumpolar Health. 2012;19(71):17996. [Online]: https://doi.org/https://doi.org/10.3402/ijch.v71i0.17996
- Fletcher C, Riva M. Introduction: la santé des Inuit ». Études/Inuit/Studies. 2016;40(1):5‑13.
- Gautier L, Pirkle CM, Furgal C, et al. Assessment of the implementation fidelity of the arctic char distribution project in Nunavik, Quebec. BMJ Glob Health. 2016;1,3. [Online] https://gh.bmj.com/content/1/3/e000093
- Healey GK, Meadows LM. Inuit women’s health in Nunavut, Canada: a review of the literature. Int J Circumpolar Health. 2007;66(3):199–214. [Online]: https://doi.org/https://doi.org/10.3402/ijch.v66i3.18256
- Hordyk SR, Macdonald ME, Brassard P. Inuit interpreters engaged in end-of-life care in Nunavik, Northern Quebec. Int J Circumpolar Health. 2017;76(1):1291868. [Online]. https://doi.org/https://doi.org/10.1080/22423982.2017.1291868.
- Burns PB, Rohrich RJ, Chung KC. The levels of evidence and their role in evidence-based medicine. Plast Reconstr Surg. 2011;128(1):305–310.
- Fletcher C. Changing contexts and roles of regional health knowledge and surveys in Nunavik. In: Jackson HM, editor. Québec policy on the arctic: challenges and perspectives canadian studies center. School of International Studies, University of Washington, Seattle; 2015. Arctic and International Relations: Reports and Proceedings Fall 2015, Issue 1:55–59.
- Smylie J, Kirst M, McShane K, et al. Understanding the role of Indigenous community participation in Indigenous prenatal and infant-toddler health promotion programs in Canada: A realist review. Soc Sci Med. 2016;150:128–143.
- Epoo B, Stonier J, Van Wagner V, et al. Learning Midwifery in Nunavik: community-based education for Inuit Midwives. J Aborig Indigen Communi Health. 2012;10(3):283–299. pimatisiwin.com/online/wp-content/uploads/2013/02/03EpooStonier.pdf
- Morris M. Inuit involvement in developing a participatory action research project on youth, violence prevention, and health promotion. Études/Inuit/Studies. 2016;40(1):105–125.
- Jenkins AL, Gyorkos TW, Culman KN, et al. An overview of factors influencing the health of Canadian Inuit infants. Int J Circumpolar Health. 2003;62(1). [Online]. https://doi.org/https://doi.org/10.3402/ijch.v62i1.17526
- Paquin V, Sandy G, Perrault-Sullivan G, et al. Twenty ‘must-read’ research articles for primary care providers in Nunavik: scoping study and development of an information tool. Int J Circumpolar Health. 2019;78(1). [Online]. https://doi.org/https://doi.org/10.1080/22423982.2019.1578638